|
⚲
|
| Fiduciary Benchmarks Insights LLC | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001472419 |
| Sale | 2009-09-08 ($1.5 M Offered, $1.5 M Sold) |
| Fund | |
| Phone | 5035464909 |
| Address | 111 SW Columbia, Suite 1080 Portland, 97201 |
| Source | [EDGAR] |
| Fund AUM and Sold ($k) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Thomas Kmak | |
| David Bodmer |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Cancer Targeting Systems, Inc.
✚
|
0.0 | |
|
ATeams, Inc.
✚
|
0.0 | |
|
ATS 218, a series of SAX Capital Series Fund III, LP
✚
|
0.0 | |
|
AU Fund I, a series of 5 Eyes Ventures, LP
✚
|
0.0 | |
|
AU Fund I, a series of Matt Bilotti AL Funds, LP
✚
|
0.0 | |
|
AU Fund I, a series of Ride Wave Ventures, LP
✚
|
0.0 | |
|
SAB IV Financial Industries Partnership L.P.
✚
|
0.0 | |
|
Diameter Credit (BDC) Access LP
✚
|
0.0 | |
|
Diamondback Acquisition, Inc.
✚
|
0.0 | |
|
Canamed, Inc.
✚
|
0.0 |